All Stories

  1. Effect of quantum iterative reconstruction on coronary stent assessment in ultra-high resolution photon-counting detector CT: a phantom study
  2. Coronary plaque burden as a determinant of cardiovascular outcomes in patients undergoing percutaneous coronary intervention versus coronary artery bypass grafting: The Western Denmark Heart Registry
  3. Influence of Intensive Lipid-Lowering With Statin and Ezetimibe Prescription on Computed Tomography–Derived Fractional Flow Reserve in Patients With Stable Chest Pain
  4. The association of risk factors on coronary computed tomography angiography derived atherosclerotic plaque volume - Lessons from the ADVANCE registry
  5. Long-term prognostic impact of complete revascularisation defined by CT-derived fractional flow reserve
  6. Seven-year Prognostic Value of Coronary CT Angiography–derived Fractional Flow Reserve in Stable Angina
  7. Rationale and design of VICAD-RISK study: Visualization of coronary artery disease for modification of risk factors
  8. Low-density lipoprotein cholesterol and cardiovascular risk in the absence of calcifications on computed tomography: the Western Denmark Heart Registry
  9. Good FFRCT Test-Retest Reproducibility
  10. Coronary artery calcification score and 19 biomarkers on cardiovascular events; a 10-year follow-up DanRisk substudy
  11. Interscan reproducibility of computed tomography derived coronary plaque volume measurements
  12. Selective FFRCT testing in suspected stable angina in clinical practice - initial experiences
  13. Completeness of revascularization by FFRCT in stable angina: Association to adverse cardiovascular outcomes
  14. Association of Autoimmune Diseases With Coronary Atherosclerosis Severity and Ischemic Events
  15. Coronary computed tomography angiography derived fractional flow reserve and risk of recurrent angina: A 3-year follow-up study
  16. Impact of Smoking on Coronary Volume–to–Myocardial Mass Ratio: An ADVANCE Registry Substudy
  17. Interaction of AI-Enabled Quantitative Coronary Plaque Volumes on Coronary CT Angiography, FFR CT , and Clinical Outcomes: A Retrospective Analysis of the ADVANCE Registry
  18. Impact of Coronary CT Angiography–derived Fractional Flow Reserve on Downstream Management and Clinical Outcomes in Individuals with and without Diabetes
  19. Prognostic Value of Coronary CT Angiography–derived Fractional Flow Reserve on 3-year Outcomes in Patients with Stable Angina
  20. Coronary Volume to Left Ventricular Mass Ratio in Patients With Hypertension
  21. Influence of Obesity on Coronary Artery Disease and Clinical Outcomes in the ADVANCE Registry
  22. Influence of intensive lipid‐lowering on CT derived fractional flow reserve in patients with stable chest pain: Rationale and design of the FLOWPROMOTE study
  23. Coronary volume to left ventricular mass ratio in patients with diabetes mellitus
  24. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19
  25. Is CT-derived fractional flow reserve superior to ischemia testing?
  26. Association of Coronary Plaque With Low-Density Lipoprotein Cholesterol Levels and Rates of Cardiovascular Disease Events Among Symptomatic Adults
  27. Trans-lesional fractional flow reserve gradient as derived from coronary CT improves patient management: ADVANCE registry
  28. Interplay of Risk Factors and Coronary Artery Calcium for CHD Risk in Young Patients
  29. Reduction of Myocardial Infarction and All-Cause Mortality Associated to Statins in Patients Without Obstructive CAD
  30. Coronary CT angiography-derived fractional flow reserve in-stable angina: association with recurrent chest pain
  31. Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World
  32. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia
  33. Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe
  34. The clinical utility of FFRCT stratified by age
  35. Heterogenous Distribution of Risk for Cardiovascular Disease Events in Patients With Stable Ischemic Heart Disease
  36. Temporal changes in FFRCT-Guided Management of Coronary Artery Disease – Lessons from the ADVANCE Registry
  37. Impact of Plaque Burden Versus Stenosis on Ischemic Events in Patients With Coronary Atherosclerosis
  38. Sex Differences in Coronary Computed Tomography Angiography–Derived Fractional Flow Reserve
  39. Extent of arterial calcification by conventional vitamin K antagonist treatment
  40. Implementation of coronary computed tomography angiography as nationally recommended first-line test in patients with suspected chronic coronary syndrome: impact on the use of invasive coronary angiography and revascularization
  41. CAD Severity on Cardiac CTA Identifies Patients With Most Benefit of Treating LDL-Cholesterol to ACC/AHA and ESC/EAS Targets
  42. Coronary flow impairment in asymptomatic patients with early stage type-2 diabetes: Detection by FFR CT
  43. Clinical outcomes following real-world computed tomography angiography-derived fractional flow reserve testing in chronic coronary syndrome patients with calcification
  44. Coronary CT Angiography-derived Fractional Flow Reserve Testing in Patients with Stable Coronary Artery Disease: Recommendations on Interpretation and Reporting
  45. Pressure Recovery in the Left Main Stenosis
  46. Prediction of Coronary Revascularization in Stable Angina
  47. The Authors’ Reply:
  48. The Authors’ Reply:
  49. Carotid plaque composition by CT angiography in asymptomatic subjects: a head-to-head comparison to ultrasound
  50. 1-Year Impact on Medical Practice and Clinical Outcomes of FFRCT
  51. Sex difference in fibrin clot lysability: Association with coronary plaque composition
  52. Prospective Comparison of FFR Derived From Coronary CT Angiography With SPECT Perfusion Imaging in Stable Coronary Artery Disease
  53. Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve: lessons from the ADVANCE Registry
  54. Genome-wide analysis of genetic determinants of circulating factor VII-activating protease (FSAP) activity
  55. Sex differences in coronary plaque composition evaluated by coronary computed tomography angiography in newly diagnosed Type 2 diabetes: association with low-grade inflammation
  56. External validity of a cardiovascular screening including a coronary artery calcium examination in middle-aged individuals from the general population
  57. The association between uric acid levels and different clinical manifestations of coronary artery disease
  58. Prognostic value of suPAR and hs-CRP on cardiovascular disease
  59. Incidence and predictors of lesion-specific ischemia by FFR CT : Learnings from the international ADVANCE registry
  60. Prevalence of coronary artery calcification in a non-specific chest pain population in emergency and cardiology departments compared with the background population: a prospective cohort study in Southern Denmark with 12-month follow-up of cardiac endpo...
  61. Sex difference in clot lysability and association to coronary artery calcification
  62. Factor VII-activating protease
  63. Coronary CT Angiography Derived Fractional Flow Reserve: The Game Changer in Noninvasive Testing
  64. High burden of coronary atherosclerosis in patients with a new diagnosis of type 2 diabetes
  65. CT-Detected Growth of Coronary Artery Calcification in Asymptomatic Middle-Aged Subjects and Association With 15 Biomarkers
  66. Lack of association between cystatin C and different coronary atherosclerotic manifestations
  67. Rationale, design and goals of the HeartFlow assessing diagnostic value of non-invasive FFR CT in Coronary Care (ADVANCE) registry
  68. Prognostic assessment of stable coronary artery disease as determined by coronary computed tomography angiography: a Danish multicentre cohort study
  69. Associations between calcium-phosphate metabolism and coronary artery calcification; a cross sectional study of a middle-aged general population
  70. Association between high-sensitive troponin I and coronary artery calcification in a Danish general population
  71. Coronary Computed Tomography Angiography Derived Fractional Flow Reserve and Plaque Stress
  72. Visualization of Coronary Artery Calcification: Influence on Risk Modification
  73. Increased discordance between HeartScore and coronary artery calcification score after introduction of the new ESC prevention guidelines
  74. Coronary calcification among 3477 asymptomatic and symptomatic individuals
  75. The Western Denmark Cardiac Computed Tomography Registry: a review and validation study
  76. Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjects
  77. Uncontrolled hypertension is associated with coronary artery calcification and electrocardiographic left ventricular hypertrophy: a case-control study
  78. Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?
  79. Plasma copeptin as marker of cardiovascular disease in asymptomatic type 2 diabetes patients
  80. P228Association of vessel wall changes with cardiovascular risk markers in healthy individuals
  81. Lack of Correlation Between Depression and Coronary Artery Calcification in a Non-Selected Danish Population
  82. Ability of HeartScore to identify coronary calcifications: Results from the DanRisk Study and the Heinz Nixdorf Recall study
  83. Coronary artery calcification and cardiovascular risk factors in 3477 asymptomatic and symptomatic individuals
  84. Social factors and coping status in asymptomatic middle-aged Danes: Association to coronary artery calcification
  85. An ELISA for the quantitation of von Willebrand Factor: Osteoprotegerin complexes in plasma
  86. Coronary artery calcification and ECG pattern of left ventricular hypertrophy or strain identify different healthy individuals at risk
  87. Non-invasive assessments reveal that more than half of randomly selected middle-aged individuals have evidence of subclinical atherosclerosis: a DanRisk substudy
  88. Population Screening for Coronary Artery Calcification Does Not Increase Mental Distress and the Use of Psychoactive Medication
  89. The relation between coronary artery calcification in asymptomatic subjects and both traditional risk factors and living in the city centre: a DanRisk substudy
  90. Changes in medical treatment six months after risk stratification with HeartScore and coronary artery calcification scanning of healthy middle-aged subjects
  91. Discrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: the DanRisk study
  92. In-hospital resuscitation evaluated by in situ simulation: a prospective simulation study
  93. Women with acute coronary syndrome are less invasively examined and subsequently less treated than men
  94. Sestamibi single photon emission computed tomography immediately after primary percutaneous coronary intervention identifies patients at risk for large infarcts
  95. Arterial concentration of 99mTc-sestamibi at rest, during peak exercise and after dipyridamole infusion
  96. Electrocardiographic Gated 99mTc-Sestamibi SPECT Immediately after Primary Percutaneous Coronary Intervention Characterizes Reperfusion Success
  97. 7.9 Can 99mTc-MIBI SPECT delineate myocardial viability in patients with severe left-ventricular dysfunction by use of a simple 50% cut-off?
  98. 99m Tc-Sestamibi SPECT is a Useful Technique for Viability Detection. Results of a Comparison with NH 3 /FDG PET
  99. R-wave Changes in Fatal Air Embolism During Bone Cementation
  100. Myocardial perfusion imaging in breast cancer patients treated with or without post-mastectomy radiotherapy
  101. Functional significance of recruitable collaterals during temporary coronary occlusion evaluated by 99mTc-sestamibi single-photon emission computerized tomography
  102. Clinical Assessment of Indication for ACE-Inhibitor Treatment Early After Acute Myocardial Infarction
  103. Perioperative myocardial ischaemia in patients undergoing surgery for fractured hip randomized to incremental spinal, single-dose spinal or general anaesthesia
  104. Evaluation of regional myocardial perfusion in patients with severe left ventricular dysfunction: Comparison of 13N-ammonia PET and 99mTc sestamibi SPECT
  105. Adjuvant radiotherapy in breast cancer and risk of ischaemic heart disease
  106. Functional significance of coronary collaterals during exercise assessed by 99mTc-sestamibi SPECT in patients with one-vessel disease
  107. Somatic and social prognosis of patients with angina pectoris and normal coronary arteriography: a follow-up study